TrialEuropean journal of neurology2024

In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis.

Joachim Schuster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.